Array Biopharma, Inc. (ARRY) Tops Q2 EPS by 3c

February 4, 2014 8:07 AM

Array Biopharma, Inc. (NASDAQ: ARRY) reported Q2 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found